Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Olga S. Samoilova"'
Autor:
Tatiana E. Bialik, Vladimir I. Vorob'ev, Valerii A. Ionin, Loic Ysebaert, Kamil D. Kaplanov, Larisa P. Mendeleeva, Evgenii A. Nikitin, Vadim V. Ptushkin, Olga S. Samoilova, Elena A. Stadnik
Publikováno v:
Современная онкология, Vol 23, Iss 3, Pp 404-406 (2021)
Over the past decades, there has been a significant expansion of the treatment options for patients with chronic lymphocytic leukemia (CLL) due to Brutons tyrosine kinase (BTK) inhibitors, which changed approaches in CLL therapy. Ibrutinib was the fi
Externí odkaz:
https://doaj.org/article/1c92f70a6bda4d418cdf39c54aceadf2
Autor:
Irina V. Poddubnaya, Lyubov S. Al-Radi, Tatyana E. Byalik, Kamil D. Kaplanov, Valentina Z. Molostvova, Evgeniy A. Nikitin, Tatyana I. Pospelova, Vadim V. Ptushkin, Olga S. Samoilova, Elena A. Stadnik, Gayane S. Tumyan
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 31-33 (2020)
Over the past decade, we have seen a significant change in modern approaches in the first-line treatment of chronic lymphocytic leukemia (CLL). The CLL-10 study data established the FCR regimen as the treatment of choice for younger patients with lim
Externí odkaz:
https://doaj.org/article/67aed2307be24cdebf0808eebbc30d52
Autor:
Michel, Delforge, Evangelos, Terpos, Paul G, Richardson, Ofer, Shpilberg, Nuriet K, Khuageva, Rudolf, Schlag, Meletios A, Dimopoulos, Martin, Kropff, Ivan, Spicka, Maria T, Petrucci, Olga S, Samoilova, Maria-Victoria, Mateos, Hila, Magen-Nativ, Hartmut, Goldschmidt, Dixie-Lee, Esseltine, Deborah S, Ricci, Kevin, Liu, William, Deraedt, Andrew, Cakana, Helgi, van de Velde, Jesús F, San Miguel
Publikováno v:
European journal of haematology. 86(5)
Bone disease is a key presenting feature of myeloma. This post hoc analysis of the phase III VISTA trial of bortezomib plus melphalan-prednisone (VMP) vs. MP in previously untreated myeloma patients assessed clinical bone disease events and changes i